Recent Advances in Translational Pediatric Oncology

The inaugural Children’s Hospital of Philadelphia’s Center for Childhood Cancer Research (CCCR) Scientific Symposium entitled “Recent Advances in Pediatric Translational Oncology” will be held on Thursday October 25, 2012. We believe that this event represents not only the strong partnership between the Children’s Hospital of Philadelphia and the Alex’s Lemonade Stand Foundation, but also that this will be a productive and outstanding day. The symposium will focus on cutting-edge research impacting the field of cancer in general, with particular relevance to the pediatric cancer problem.  We look forward to hearing about not only the latest discoveries in oncology research, but we also hope to address the challenges and opportunities that the pediatric oncology community faces in the area of translational oncology. We have attached below the proposed schedule for the conference.

For questions and additional information, please contact John Simpkins at This email address is being protected from spambots. You need JavaScript enabled to view it. or 267-426-0948

2012 Center for Childhood Cancer Research Symposium:

Recent Advances in Translational Pediatric Oncology

Thursday October 25th 2012

Symposium Location – Children’s Hospital of Philadelphia, Colket Translational Research Building, 3501 Civic Center Boulevard – First Floor.

http://www.research.chop.edu/programs/cccr/index.php/about/colket-translational-research-building.html

7:00 – 9:00 a.m.                 Registration, Colket Lobby

7:00 – 8:30 a.m.                 Continental Breakfast, Colket 1100B

8:30 – 9:00 a.m.                 Welcome and Opening Remarks (Colket 1200 A/B)

Session I:  (Chaired by Drs David Teachey and John Maris), Colket 1200 A/B

9:00–9:45 a.m.                   Michael Kastan, MD, PhD, Duke Cancer Institute

                                              Therapeutic Targeting of DNA Damage Response Pathways

9:45 – 10:30 a.m.               Adolfo Ferrando, MD, PhD, Columbia University

                                              Oncogenic Pathways in T-ALL

10:30 – 10:45 a.m.             Coffee Break

10:45 – 11:30 a.m.             Stephan Grupp, MD, PhD, Children’s Hospital of Philadelphia

                                              Highly Active Cell Therapy for Pediatric Malignancies

11:30 – 12:15 p.m.             Kevin Shannon, MD, University of California San Francisco

                                              Translating Molecular Mechanisms into Rational Therapeutic Strategies for Childhood Leukemia

12:15 – 1:15 p.m.               Lunch will be provided for registered participants, Colket 1100B

Session II: (Chaired by Drs Tom Curran and Kristina Cole), Colket 1200 A/B

1:15 – 2:00 p.m.                 Richard Gilbertson, MD, PhD, St Jude Children’s Research Hospital

                                              Mapping Cancer Origins

2:00 – 2:45 p.m.                 Matthew Meyerson, MD, PhD, Harvard Medical School & Broad Institute

                                              Somatic Genome Alterations in Pediatric Solid Tumors

2:45 – 3:00 p.m.                 Coffee Break

3:00 – 3:45 p.m.                 Yaël Mossé, MD, Children’s Hospital of Philadelphia

                                              Targeting ALK in Neuroblastoma: Opportunities and Challenges

3:45 – 4:30 p.m.                 Peter Lebowitz, MD, PhD, Global Oncology Therapeutics, Johnson and Johnson

                                              New Paradigms for Oncology Drug Development

4:30 – 4:45 p.m.                 Concluding Remarks

5:00 – 6:30 p.m.                 Evening Reception, Colket Lobby

Program Organizing Committee:

Kristina Cole MD, PhD
David Teachey MD
John Maris MD
John Simpkins MBA